The innovative immunotherapy method known as CAR T-cell therapy has showed exceptional promise in the treatment of a variety of malignancies. Beijing, China’s Peking University Cancer Hospital has become a global leader in the development of CAR T-cell treatment. With the help of their multidisciplinary team, which consists of oncologists, immunologists, and geneticists, personalized cancer treatment has advanced significantly. Peking University Cancer Hospital has obtained outstanding outcomes in patients with haematological malignancies by altering patients’ own T cells to express chimeric antigen receptors (CARs). This cutting-edge treatment gives cancer patients fresh hope while revolutionizing the field of oncology and raising survival rates.
- Established_In 1976
- Hospital_Grade Top three specialist hospitals
Specialities
- lymphoma
- myeloma
- leukemia
- lung cancer
- stomach cancer
- colorectal cancer
- esophageal cancer
- breast cancer
- liver cancer
- pancreatic cancer
- ovarian cancer
- cervical cancer
- kidney cancer
